相似文献
1
Expression analysis of cyclin D, Ki-67, MCM3 and MCM2 in oral squamous cell carcinoma.
Bioinformation. 2023 Dec 31;19(13):1405-1410. doi: 10.6026/973206300191405. eCollection 2023.
2
Comparative evaluation of immunohistochemical expression of MCM2 and Ki67 in oral epithelial dysplasia and oral squamous cell carcinoma.
J Cancer Res Ther. 2022 Jul-Sep;18(4):997-1002. doi: 10.4103/jcrt.JCRT_10_20.
3
Immunohistochemical expression and evaluation of cyclin D1 and minichromosome maintenance 2 in oral squamous cell carcinoma and verrucous carcinoma.
J Oral Maxillofac Pathol. 2022 Jan-Mar;26(1):44-51. doi: 10.4103/jomfp.jomfp_446_21. Epub 2022 Mar 31.
4
MCM3: A Novel Proliferation Marker in Oral Squamous Cell Carcinoma.
Appl Immunohistochem Mol Morphol. 2018 Feb;26(2):120-125. doi: 10.1097/PAI.0000000000000397.
5
Cyclin d1 expression and its correlation with histopathological differentiation in oral squamous cell carcinoma.
ScientificWorldJournal. 2012;2012:978327. doi: 10.1100/2012/978327. Epub 2012 May 2.
6
Evaluation of the Ki-67 and MCM3 Expression in Cytologic Smear of Oral Squamous Cell Carcinoma.
J Dent (Shiraz). 2017 Sep;18(3):207-211.
7
Ki-67, mini-chromosome maintenance 2 protein (MCM2) and geminin have no independent prognostic relevance for cancer-specific survival in surgically treated squamous cell carcinoma of the penis.
BJU Int. 2013 Aug;112(4):E383-90. doi: 10.1111/j.1464-410X.2012.11735.x. Epub 2013 Jan 10.
8
Expression of Mcm2, geminin and Ki67 in normal oral mucosa, oral epithelial dysplasias and their corresponding squamous-cell carcinomas.
Br J Cancer. 2009 Apr 7;100(7):1128-34. doi: 10.1038/sj.bjc.6604967. Epub 2009 Mar 17.
9
Cyclin D1 expression in oral squamous cell carcinoma and verrucous carcinoma: correlation with histological differentiation.
Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2007 Mar;103(3):e30-5. doi: 10.1016/j.tripleo.2006.09.011. Epub 2007 Jan 2.
10
MCM3 could be a better marker than Ki-67 for evaluation of dysplastic oral lesions: an immunohistochemical study.
J Oral Pathol Med. 2014 Jul;43(6):427-34. doi: 10.1111/jop.12153. Epub 2014 Jan 23.
本文引用的文献
1
Evaluation of Cyclin D1 expression in Head and Neck Squamous Cell Carcinoma.
J Clin Diagn Res. 2017 Feb;11(2):EC01-EC04. doi: 10.7860/JCDR/2017/21760.9329. Epub 2017 Feb 1.
2
MCM - 2 and Ki - 67 as proliferation markers in renal cell carcinoma: A quantitative and semi - quantitative analysis.
Int Braz J Urol. 2016 Nov-Dec;42(6):1121-1128. doi: 10.1590/S1677-5538.IBJU.2015.0388.
3
Minichromosome maintenance-2 (MCM2) expression differentiates oral squamous cell carcinoma from pre-cancerous lesions.
Malays J Pathol. 2015 Dec;37(3):253-8.
4
Prognostic role of p53 and Ki-67 immunohistochemical expression in patients with surgically resected lung adenocarcinoma: a retrospective study.
J Thorac Dis. 2015 May;7(5):822-33. doi: 10.3978/j.issn.2072-1439.2015.05.02.
5
Evaluation of Minichromosome Maintenance-3 (MCM3) in Oral Squamous Cell Carcinoma.
J Dent (Shiraz). 2015 Jun;16(2):87-92.
6
Potentially malignant disorders of the oral cavity: current practice and future directions in the clinic and laboratory.
Int J Cancer. 2015 Feb 1;136(3):503-15. doi: 10.1002/ijc.28754. Epub 2014 Feb 11.
7
MCM3 could be a better marker than Ki-67 for evaluation of dysplastic oral lesions: an immunohistochemical study.
J Oral Pathol Med. 2014 Jul;43(6):427-34. doi: 10.1111/jop.12153. Epub 2014 Jan 23.
8
MCM3 as a novel diagnostic marker in benign and malignant salivary gland tumors.
Asian Pac J Cancer Prev. 2013;14(6):3479-82. doi: 10.7314/apjcp.2013.14.6.3479.
9
Expression of p53 and Cyclin D1 in oral squamous cell carcinoma and normal mucosa: An Immunohistochemical study.
J Oral Maxillofac Pathol. 2012 May;16(2):172-7. doi: 10.4103/0973-029X.98451.
10
High MCM3 expression is an independent biomarker of poor prognosis and correlates with reduced RBM3 expression in a prospective cohort of malignant melanoma.
Diagn Pathol. 2012 Jul 17;7:82. doi: 10.1186/1746-1596-7-82.
Zotero 插件